Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
6.23
+0.08 (1.30%)
At close: Jul 25, 2025, 4:00 PM
6.43
+0.20 (3.21%)
After-hours: Jul 25, 2025, 5:44 PM EDT
Apollomics Market Cap
Apollomics has a market cap or net worth of $6.97 million as of July 25, 2025. Its market cap has decreased by -66.76% in one year.
Market Cap
6.97M
Enterprise Value
-2.03M
1-Year Change
-66.76%
Ranking
Category
Stock Price
$6.23
Market Cap Chart
Since November 26, 2021, Apollomics's market cap has decreased from $129.59M to $6.97M, a decrease of -94.62%. That is a compound annual growth rate of -54.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2025 | 6.79M | -36.88% |
| Dec 31, 2024 | 10.75M | -87.56% |
| Dec 29, 2023 | 86.40M | -37.89% |
| Dec 30, 2022 | 139.11M | 7.02% |
| Dec 30, 2021 | 129.98M | 0.30% |
| Nov 26, 2021 | 129.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 723.06B |
| Johnson & Johnson | 407.97B |
| AbbVie | 337.08B |
| Novo Nordisk | 313.06B |
| UnitedHealth Group | 252.71B |
| AstraZeneca | 228.91B |
| Novartis AG | 227.81B |
| Abbott Laboratories | 218.59B |